DrugLib.com — Drug Information Portal

Rx drug information, pharmaceutical research, clinical trials, news, and more


Nutrilib.com
A comprihensive source of nutritional information

Long-Term Safety of Trexima for Migraine in Adolescents

Information source: Pozen
Information obtained from ClinicalTrials.gov on August 08, 2008
Link to the current ClinicalTrials.gov record.

Condition(s) targeted: Migraine

Intervention: Combination Product (sumatriptan succinate / naproxen sodium) (Drug)

Phase: Phase 3

Status: Recruiting

Sponsored by: Pozen

Official(s) and/or principal investigator(s):
Clinical Trials GlaxoSmithKline, Study Chair, Affiliation: GlaxoSmithKline

Summary

This study was designed to determine long-term safety of TREXIMA compared to placebo for the treatment of acute migraine.

Clinical Details

Official title: Study TXA107977, a Long-Term Safety Study of a Combination Product Containing Sumatriptan Succinate and Naproxen Sodium for the Treatment of Migraine in Adolescents

Study design: Treatment, Non-Randomized, Open Label, Uncontrolled, Single Group Assignment, Safety Study

Primary outcome: Safety data (adverse events, laboratory and ECG changes, and vital signs) will be summarized. Data will be collected at Screen, every 3 months, through 12 months.

Secondary outcome: Efficacy and migraine symptomatology will be secondary. Data will collected daily.

Detailed description: This study was designed to determine long-term safety of TREXIMA compared to placebo for the treatment of acute migraine.

Eligibility

Minimum age: 12 Years. Maximum age: 17 Years. Gender(s): Both.

Criteria:

Inclusion Criteria:

- Subject is between 12 and 17 years old at the Screening visit.

- If subject is female, she must have a negative urine pregnancy test at screening, does

not plan to become pregnant during the course of the study and agrees to use an acceptable method of birth control (i. e., a method with a failure rate <1% or abstinence) if she is/becomes sexually active.

- Subject has migraine with or without aura (2004 ICHD-II criteria).

- Subject has history suggestive of typical migraine attacks with duration of about 2 or

more hours (untreated, or unsuccessfully treated).

- Subject has at least 2, but not more than 8, migraine attacks per month in each of the

2 months prior to the Screening visit.

- Subject has at least a 6-month history of moderate to severe migraine attacks,

sufficient to establish a definitive diagnosis of migraine.

- Subject is able to distinguish migraine from other headaches (e. g., tension-type

headaches).

- Subject and subject's parent or legal guardian are willing and able to provide

informed consent prior to entry into this treatment phase of the study.

- Subject and subject's parent or legal guardian are able to read and write English or

Spanish.

- Subject is able to understand and complete the electronic device to report treatment

information.

Exclusion Criteria:

- Subject is < 75 pounds (33. 3kg).

- Subject has ≥15 headache days per month in total, retinal (ICHD-II 1. 4), basilar

(ICHD-II 1. 26) or hemiplegic migraine (ICHD-II 1. 25), or secondary headaches.

- Subject, in the investigator's opinion, is likely to have unrecognized cardiovascular

or cerebrovascular disease (See Appendix 1, section 11. 1).

- Subject has uncontrolled hypertension (See Appendix 2, section 11. 2) or is taking any

angiotensin-converting enzyme (ACE) inhibitor or angiotensin receptor blocker.

- Subject has a history of congenital heart disease, cardiac arrhythmias requiring

medication, or a history of a clinically significant electrocardiogram abnormality that, in the investigator's opinion, contraindicates participation in this study.

- Subject has evidence or history of any ischemic vascular diseases including: ischemic

heart disease, ischemic abdominal syndromes, peripheral vascular disease or Raynaud's Syndrome, or signs/symptoms consistent with any of the above.

- Subject has evidence or history of central nervous system pathology including stroke

and/or transient ischemic attacks (TIAs), epilepsy or structural brain lesions which lower the convulsive threshold; or has been treated with an antiepileptic drug for seizure control within 5 years prior to screening.

- Subject has a history of impaired hepatic or renal function that, in the

investigator's opinion, contraindicates participation in this study.

- Subject has hypersensitivity, allergy, intolerance, or contraindication to the use of

any triptan, NSAID or aspirin (including all sumatriptan and naproxen preparations) or has nasal polyps and asthma.

- Subject is currently taking, or has taken in the previous three months, a migraine

prophylactic medication containing methysergide or dihydroergotamine; or is taking a medication that is not stabilized (i. e., change of dose within the past 2 months) for either chronic or intermittent migraine prophylaxis or for a co-morbid condition that is not stabilized.

- Subject has a recent history of regular use of opioids or barbiturates for treatment

of his/her migraine headache and/or other non-migraine pain. Regular use is defined as an average of 4 days per month over the last 6 months.

- Subject has taken, or plans to take, a monoamine oxidase inhibitor (MAOI), including

herbal preparations containing St. John's Wort (Hypericum perforatum), anytime within the 2 weeks prior to screening through 2 weeks post final study treatment.

- Subject history of any bleeding disorder or is currently taking any anti-coagulant or

any antiplatelet agent.

- Subject has evidence or history of any gastrointestinal surgery or GI ulceration or

perforation in the past six months, gastrointestinal bleeding in the past year; or evidence or history of inflammatory bowel disease.

- Subject tests positive for illicit substances on toxicology screen, or has evidence of

alcohol or substance abuse within the last year, or any concurrent medical or psychiatric condition which, in the investigator's judgment, will likely interfere with the study conduct, subject cooperation, or evaluation and interpretation of the study results, or which otherwise contraindicates participation in this clinical trial.

- Subject has participated in an investigational drug trial within the previous 4 weeks

or plans to participate in another study at any time during this study.

Locations and Contacts

Valley Neurological Headache and Research Center, Phoenix, Arizona 85014, United States; Recruiting
Carol Foster, MD, Phone: 602-331-3721
Carol Foster, MD, Principal Investigator

Neurological Physicians of Arizona, Inc., Gilbert, Arizona 85234, United States; Recruiting
William Grainger, MD, Phone: 480-610-0177
William Grainger, MD, Principal Investigator

Pediatric Neurology The Children's Clinic of Jonesboro, Jonesboro, Arkansas 72401, United States; Recruiting
Stephen Bates, MD, Phone: 870-935-6012
Stephen Bates, MD, Principal Investigator

Clinical Study Centers, Little Rock, Arkansas 72205, United States; Recruiting
Gordon Gibson, MD, Phone: 501-227-7499
Gordon Gibson, MD, Principal Investigator

Med Investigations, Fair Oaks, California 95628, United States; Recruiting
John Champlin, MD, Phone: 915-965-1111
John Champlin, MD, Principal Investigator

Fullerton Neurology and Headache, Fullerton, California 92835, United States; Recruiting
Jack Florin, MD, Phone: 714-738-0800
Jack Florin, MD, Principal Investigator

Stephen Forner, MD, Chico, California 95926, United States; Recruiting
Stephen Forner, MD, Phone: 530-894-3330
Stehpen Forner, MD, Principal Investigator

San Francisco Clinical Research Center and Headache Clinic, San Francisco, California 94109, United States; Recruiting
Jerome Goldstein, MD, Phone: 415-673-4600
Jerome Goldstein, MD, Principal Investigator

UCSDn Stroke Center, San Diego, California 92103, United States; Not yet recruiting
Christy Jackson, MD
Christy Jackson, MD, Principal Investigator

Kratzer-Graves Pediatrics, Fresno, California 93720, United States; Recruiting
James Kratzer, MD, Phone: 559-438-4100
James Kratzer, MD, Principal Investigator

California Medical Clinic for Headaches, Santa Monica, California 90404, United States; Recruiting
David Kudrow, MD, Phone: 310-315-1456
David Kudrow, MD, Principal Investigator

Irvine Center for Clinical Research Inc., Irvine, California 92618, United States; Recruiting
Elly Lee, MD, Phone: 949-753-1663
Elly Lee, MD, Principal Investigator

Philip O'Carroll MD Inc., Newport Beach, California 92660, United States; Recruiting
Philip O'Carroll, MD, Phone: 949-759-8001
Philip O'Carroll, MD, Principal Investigator

Pediatric Care, Huntington, California 92647, United States; Recruiting
Paul Qaqundah, MD, Phone: 714-842-1441
Paul Qaqundah, MD, Principal Investigator

South Bay Neurology Research Center, Redondo Beach, California 90277, United States; Recruiting
George Rederich, MD, Phone: 310-376-9492
George Rederich, MD, Principal Investigator

Socklov Medical Research, Sacramento, California 95825, United States; Recruiting
Ronald Sockolov, MD, Phone: 916-924-8707
Ronald Sockolov, MD, Principal Investigator

Neurological Research Institute of the East Bay, Walnut Creek, California 94596, United States; Recruiting
Michael Stein, MD, Phone: 925-938-5252
Michael Stein, MD, Principal Investigator

Adult and Child Neurology, Roseville, California 95678, United States; Recruiting
Nadine Yassa, MD, Phone: 916-789-8811
Nadine Yassa, MD, Principal Investigator

Northridge Neurological Center, Northridge, California 91325, United States; Recruiting
Ronald Ziman, MD, Phone: 818-349-2503
Ronald Ziman, MD, Principal Investigator

Mark S. Wallace, MD, La Jolla, California 92037, United States; Recruiting
Mark S Wallace, MD, Phone: 858-657-7030

Lynn Institute of the Rockies, Colorado Springs, Colorado 80909, United States; Recruiting
Kurt Lesh, MD, Phone: 719-636-3784
Kurt Lesh, MD, Principal Investigator

The Children's Hospital - Denver Neurology, Denver, Colorado 80218, United States; Recruiting
Tonia Sabo, MD, Phone: 720-777-9249
Tonia Sabo, MD, Principal Investigator

Hartford Headache Center, Ridgfield, Connecticut 06877, United States; Recruiting
Tayna Bilchick, MD, Phone: 860-895-3133
Tayna Bilchick, MD, Principal Investigator

Associated Neurologist of Southern Connecticut, Fairfield, Connecticut 06824, United States; Recruiting
Anthony Hong, MD, Phone: 203-333-1151
Anthony Hong, MD, Principal Investigator

Anchor Reserach A Division of Anchor Health Centers, Naples, Florida 72401, United States; Not yet recruiting
Cynthia Bell, MD, Phone: 239-262-4556
Cynthia Bell, MD, Principal Investigator

Suncoast Medical Group, St. Petersburg, Florida 33701, United States; Recruiting
Steven Cohen, MD, Phone: 727-824-7135
Steven Cohen, MD, Principal Investigator

Suncoast Medical, St. Petersberg, Florida 33701, United States; Recruiting
Steven Cohen, MD, Phone: 727-824-7132
Steven Cohen, MD, Principal Investigator

Pediatric Neurology and Epilepsy Center, Loxahatchee, Florida 33470, United States; Recruiting
Edwin Liu, MD, Phone: 561-753-8888
Edwin Liu, MD, Principal Investigator

Child Neurology Clinic, Pensacola, Florida 32504, United States; Recruiting
James Ben Renfroe, MD, Phone: 850-484-6060
James Renfroe, MD, Principal Investigator

Premiere Research Institute, West Palm Beach, Florida 33407, United States; Recruiting
Paul K Winner, MD, Phone: 561-845-0500
K Winner, MD, Principal Investigator

Savannah Neurology, PC, Savannah, Georgia 31405, United States; Recruiting
Eric Pearlman, MD, Phone: 912-353-3333
Eric Pearlman, MD, Principal Investigator

Child Neurology Associates, P.C., Atlanta, Georgia 30342, United States; Recruiting
Frank Berenson, MD, Phone: 404-256-3535
Frank Berenson, MD, Principal Investigator

Pediatric Neurology of Idaho, Boise, Idaho 83712, United States; Not yet recruiting
David Bettis, MD
David Bettis, MD, Principal Investigator

Community Clinical Research Center, Anderson, Indiana 46011, United States; Recruiting
Larry Blankenship, Jr., MD, Phone: 765-648-2420
Larry Blankenship, Jr., MD, Principal Investigator

Vince & Associates, Overland Park, Kansas 66212, United States; Not yet recruiting
Brad Vince, MD
Brad Vince, MD, Principal Investigator

CNS Associates, Inc., Murray, Kentucky 42071, United States; Recruiting
Jon Gustafson, MD, Phone: 270-753-8656
Jon Gustafson, MD, Principal Investigator

Kentucky Pediatric/Adult Relationship, Bardstown, Kentucky 40004, United States; Recruiting
James Hedrick, MD, Phone: 502-348-6309
James Hedrick, MD, Principal Investigator

Child and Adolescent Neurology, Bethesda, Maryland 20817, United States; Not yet recruiting
Jody Green, MD
Jody Green, MD, Principal Investigator

ProMed Pediatrics, Protage, Michigan 49024, United States; Recruiting
Thomas Akland, MD, Phone: 269-329-0944
Thomas Akland, MD, Principal Investigator

Women's Health Care Specialists, P.C., Paw Paw, Michigan 49079, United States; Recruiting
Roger Beyer, MD, Phone: 269-657-6058
Roger Beyer, MD, Principal Investigator

ProMed Pediatrics, Kalamazoo, Michigan 97210, United States; Not yet recruiting
Jerald Finnegan, MD, Phone: 269-381-3500
Jerald Finnegan, MD, Principal Investigator

Michigan Head Pain & Neurological Institute, Ann Arbor, Michigan 48104, United States; Recruiting
Charles Gordon, MD, Phone: 734-677-6000
Charles Gordon, MD, Principal Investigator

Borgess Research Institute, Kalamazoo, Michigan 49043, United States; Recruiting
Sandra Wiederhold, MD, Phone: 269-552-2500
Sandra Wiederhold, MD, Principal Investigator

Clinical Research Institute, Minneapolis, Minnesota 55402, United States; Recruiting
Gary Berman, MD, Phone: 612-333-2200
Gary Berman, MD, Principal Investigator

Mercy Health Research Ryan Headache Center, St. Louis, Missouri 63141, United States; Recruiting
Jim Banks III, MD, Phone: 314-251-8890
Jim Banks, MD, Principal Investigator

Midwest Allergy and Asthma Clinic, Omaha, Nebraska 68130, United States; Not yet recruiting
Tom Nilsson, MD
Tom Nilsson, MD, Principal Investigator

Lovelace Scientific Resources, Inc., Las Vegas, Nevada 89148, United States; Recruiting
Shanker Dixit, MD, Phone: 702-796-5505
Shanker Dixit, MD, Principal Investigator

Dartmouth Hitchcock Medical Center, Lebanon, New Hampshire 03756, United States; Not yet recruiting
Levin Morris, MD
Levin Morris, MD, Principal Investigator

Childrens Neurology, Morristown, New Jersey 07960, United States; Not yet recruiting
Trevor De Souza, MD
Trevor De Souza, MD, Principal Investigator

Pediatric Clinical Research Center, New Brunswick, New Jersey 08901, United States; Recruiting
Rajeshwari Mahalingam, MD, Phone: 732-235-7875
Rajeshwari Mahalingam, MD, Principal Investigator

The Center for Neurological & Neurodevelopmental Health Clinical Research Center of New Jersey, Voorhees, New Jersey 08043, United States; Recruiting
Mark Mintz, MD, Phone: 856-616-6439
Mark Mintz, MD, Principal Investigator

Lovelace Scientific Resources, Albuquerque, New Mexico 87108, United States; Recruiting
Eileen Brady, MD, Phone: 505-348-9500
Eileen Brady, MD, Principal Investigator

Braverman-Panza Medical Group, Albany, New York 12206, United States; Recruiting
Jill Braverman-Panza, MD, Phone: 518-482-0007
Jill Braverman-Panza, MD, Principal Investigator

Rochester Clinical Research, Rochester, New York 14609, United States; Recruiting
Matthew Davis, MD, Phone: 585-288-0890
Matthew Davis, MD, Principal Investigator

University of Rochester, Rochester, New York 14642, United States; Recruiting
Deborah Friedman, MD, Phone: 585-273-3937
Deborah Friedman, MD, Principal Investigator

Gosy & Associates Pain Treatment and Neurology, LLP, Williamsville, New York 14221, United States; Recruiting
Eugene Gosy, MD, Phone: 716-626-9900
Eugene Gosy, MD, Principal Investigator

The Elkind Headache Clinic, Mt Vernon, New York 10550, United States; Recruiting
Arthur H Elkind, MD, Phone: 914-668-6195
Arthur H Elkind, MD, Principal Investigator

Neurology Group of Bergen County, P. A., Ridgewood, New York 07450, United States; Not yet recruiting
Kenneth Levin, MD, Phone: 201-444-0868
Kenneth Levin, MD, Principal Investigator

Dent Neurologic Institute, Amherst, New York 14226, United States; Recruiting
Laszlo Mechtler, MD, Phone: 716-961-9900
Laszlo Machtler, MD, Principal Investigator

Analgesic Development Ltd., New York, New York 10022, United States; Not yet recruiting
Serena Mulhern, MD, Phone: 212-249-2550
Serena Mulhern, MD, Principal Investigator

Regional Clinical Research, Endwell, New York 13760, United States; Recruiting
Duncan Sze-Tu, MD, Phone: 607-754-3863
Duncan Sze-Tu, MD, Principal Investigator

Island Neurological Associates, Plainview, New York 11803, United States; Recruiting
Ira Turner, MD, Phone: 516-822-2230
Ira Turner, MD, Principal Investigator

Raleigh Neurology Associates, Raleigh, North Carolina 27607, United States; Recruiting
Kevin Rathke, MD, Phone: 919-782-3456
Kevin Rathke, MD, Principal Investigator

Cincinnati Children's Hospital, Cincinnati, Ohio 45229, United States; Recruiting
Andrew Hershey, MD, Phone: 513-636-4222
Andrew Hershey, MD, Principal Investigator

OrthoNeuro, Westerville, Ohio 43018, United States; Recruiting
Francis O'Donnell, MD, Phone: 614-890-6555
Francis O'Donnell, MD, Principal Investigator

Childrens Hospital, Columbus, Ohio 43018, United States; Recruiting
Ann Pakalnis, MD, Phone: 614-722-2000
Ann Pakalnis, MD, Principal Investigator

Cleveland Clinic Foundation, Cleveland, Ohio 44195, United States; Recruiting
David Rothner, MD, Phone: 216-444-5514
David Rothner, MD, Principal Investigator

Lynn Health Science Institute, Oklahama City, Oklahoma 73112, United States; Recruiting
Mark Fisher, MD, Phone: 405-602-3939
Mark Fisher, MD, Principal Investigator

Pacific Women's Center, Eugene, Oregon 97401, United States; Recruiting
Richard Beyerlein, MD, Phone: 541-342-8616
Richard Beyerlein, MD, Principal Investigator

Medford Neurologic Spine Center, Medford, Oregon 97504, United States; Recruiting
Walter Carlini, MD, Phone: 541-779-1672
Carlini Walter, MD, Principal Investigator

Oregon Center for Clinical Investigations, Inc., Portland, Oregon 97210, United States; Recruiting
Beal Essink, MD, Phone: 503-276-6224
Beal Essink, MD, Principal Investigator

Mountain View Clinical Research, Greer, South Carolina 29349, United States; Recruiting
Phillip Snell, MD, Phone: 864-334-0141
Phillip Snell, MD, Principal Investigator

Nashville Neurosciences Group, Nashville, Tennessee 37203, United States; Recruiting
Jan Brandes, MD, Phone: 615-284-4680
Jan Brandes, MD, Principal Investigator

Neurology, Headache & Pain Control Center, Nassau Bay, Texas 77058, United States; Recruiting
Moshe Allon, MD, Phone: 281-338-7246
Allon Moshe, MD, Principal Investigator

Texas Child Neurology, Plano, Texas 75075, United States; Recruiting
Robert Chudnow, MD, Phone: 972-769-9000
Robert Chudnow, MD, Principal Investigator

Radiant Research, San Antonio, Texas 78229, United States; Recruiting
William Jennings, MD, Phone: 210-614-7483
William Jennings, MD, Principal Investigator

Dallas Pediatric Neurology Associates, Dallas, Texas 75230-2507, United States; Recruiting
Steven Linder, MD, Phone: 972-566-8600
Steven Linder, MD, Principal Investigator

Georgetown Medical Center Clinic, Georgetown, Texas 78628, United States; Recruiting
John Willis, MD, Phone: 512-930-4593
John Willis, MD, Principal Investigator

Foothill Family Clinic South, Salt Lake City, Utah 84121, United States; Recruiting
Shane Christensen, MD, Phone: 801-365-1032
Shane Christensen, MD, Principal Investigator

J. Lewis Research, Inc., Salt Lake City, Utah 84109, United States; Recruiting
Dan Henry, MD, Phone: 801-487-2072
Dan Henry, MD, Principal Investigator

Monarch Medical Research, Norfolk, Virginia 23510, United States; Recruiting
Donald Lewis, MD, Phone: 757-668-9920
Donald Lewis, MD, Principal Investigator

Pedeatric Research of Charlottesville, LLC, Charolottesville, Virginia 22902, United States; Recruiting
Paul Wisman, MD, Phone: 434-326-0411
Paul Wisman, MD, Principal Investigator

Kitsap Center for Clinical Studies, Bremerton, Washington 98310, United States; Recruiting
Donald Bright, MD, Phone: 360-377-9079
Donald Bright, MD, Principal Investigator

Wenatchee Valley Medical Center, Wenatchee, Washington 98801, United States; Recruiting
Steven Kaster, MD, Phone: 509-665-5800
Steven Kaster, MD, Principal Investigator

Additional Information

Starting date: June 2007
Ending date: August 2008
Last updated: July 23, 2008

Page last updated: August 08, 2008

-- advertisement -- The American Red Cross

We comply with
HONcode standard.
Verify here.
Home | About Us | Contact Us | Site usage policy | Privacy policy

All Rights reserved - Copyright DrugLib.com, 2006-2008